Background
We tested the effect of weight-loss on circulating levels of the angiogenic factors vascular endothelial growth factor (VEGF), and pigment epithelium-derived factor (PEDF) in postmenopausal overweight/obese women, 18 months after completing a year-long 4-arm randomized controlled trial of behavioral weight loss and/or exercise vs. control (i.e., 30-months post-randomization).
Methods
439 overweight/obese, postmenopausal women, 50–75 years, were randomized to: diet (goal: 10% weight-loss, N=118), exercise (225 min/week moderate-to-vigorous activity, N=117), diet+exercise (N=117), or control (N=87). At 12-months, 399 women gave a blood sample; 156 returned at 30-months. Biomarkers were measured by immunoassay. Changes were compared using generalized estimating equations, adjusting for baseline BMI, age, and race/ethnicity.
Results
Participants randomized to diet, exercise and diet+exercise arms had greater reductions in VEGF at 30 months (−14.1% P=0.02; −19.7% P=0.003; −14.5% P=0.002, respectively), vs. controls (−4.5%). There were no statistically significant changes in PEDF in any intervention arm. Participants maintaining ≥10% of baseline weight-loss at 30-months had greater reductions in VEGF vs. those who gained weight/had no weight change (−22.3% vs. −10.2% respectively, P=0.002). Participants maintaining any weight loss had significantly lower levels of PEDF at 30 months vs. those who gained weight/no weight change.
Conclusion
Sustained weight loss via diet and/or exercise results in reductions in angiogenic factors, and can be maintained up to 30-month follow-up. Limitations include relatively small numbers, and possible bias towards more successful weight-loss among women who returned at 30 months.